Annapolis Financial Services’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-77
Closed -$1K 466
2022
Q3
$1K Hold
77
﹤0.01% 472
2022
Q2
$1K Hold
77
﹤0.01% 409
2022
Q1
$1K Hold
77
﹤0.01% 431
2021
Q4
$2K Hold
77
﹤0.01% 407
2021
Q3
$3K Hold
77
﹤0.01% 372
2021
Q2
$4K Hold
77
﹤0.01% 329
2021
Q1
$3K Hold
77
﹤0.01% 336
2020
Q4
$5K Buy
+77
New +$3.16K ﹤0.01% 299

Other funds holding EDIT

Annapolis Financial Services's EDIT Position: Q4 2022 in Review

Annapolis Financial Services sold out of Editas Medicine (EDIT) in Q4 2022, closing a stake of 77 shares — an estimated $1K sold.

Annapolis Financial Services first reported a position in EDIT in Q4 2020 and held it in 8 quarters. The position peaked at $5K in Q4 2020. 250 funds tracked by Wall St. Rank hold EDIT as of Q4 2022.

  • Annapolis Financial Services reported no remaining Editas Medicine position as of Q4 2022 after selling out during the quarter.
  • Annapolis Financial Services sold 77 Editas Medicine shares in Q4 2022, an estimated $1K.
  • Annapolis Financial Services first reported a position in Editas Medicine in Q4 2020 and held it in 8 quarters.
  • Annapolis Financial Services's Editas Medicine position peaked at $5K in Q4 2020.
  • 250 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2022.

Based on Annapolis Financial Services's 13F filing for Q4 2022, filed 23 Jan 2023.